Here, we hypothesized that lentinan might also bind to the CD133 on the surface of CRC cells and inhibit its expression, thus affecting the downstream signal pathway and inhibiting the stemness of CRC cells, thereby exerting anti-tumor effects. Here, PROM1 is linked to neoplasm.